Neurocognitive Function After Proton Therapy in Children and Adolescents

Recruiting Observational Study
Primary Brain Tumor
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
8 – 18
Sex
Any
Study type
Observational
Participants needed
90 (estimated)
Sponsor
Technische Universität Dresden · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Brain tumors are the second most frequent malignant diseases in children and adolescents. In the study the short and medium term consequences of proton therapy on cognitive processes in particular on executive functions in pediatric patients shall be highlighted/analysed/evalutated. In a second step, these results are to be compared with 1. a group of children and adolescents who had only /exclus…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Indication: Patients with primary brain tumor Inclusion Criteria: * all groups: Patients in childhood and adolescence between 8-18 years of age * all groups: no prior radiotherapy of the brain, * all groups: The patient is able to perform repeated neuropsychological tests (approx. 1 hour per exami…
Contacts

Mechthild Krause, Prof. Dr.

+49 351 458 2238

mechthild.krause@uniklinikum-dresden.de

CONTACT